Project Grant R35GM155208

Award Date 7/1/24
Completion Date 6/30/29
Dollars Obligated $1.2M
Federal Grant Program
93.859
Assistance Type
Project Grant
Place of Performance
College Park, MD 20742, USA
Similar Awards
This $2,279,811 Project Grant award from the National Institutes of Health (NIH) Office of the Director under the Trans-NIH Research Support program (CFDA 93.310) will enable research to develop novel activity-based probes (ABPs) to directly characterize enzymatic function and microbial mechanisms within the gut microbiome. The primary awardee, Weill Medical College of Cornell University, will synthesize ABPs targeting key enzyme classes to provide enhanced functional resolution of the gut...
This federal Project Grant award of $372,500.00 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training program (CFDA 93.859) supports research at the University of Wisconsin-Parkside to characterize the enzymatic activities and metabolic functions of key gut bacteria in the Bacteroides genus. The research aims to provide clarity on fatty acid metabolism and coenzyme A availability within these bacteria, which have important implications for...
This $325,139 federal Project Grant award, funded by the National Center for Advancing Translational Sciences (NCATS), 93.350 program, aims to examine the feasibility of using target-specific polyclonal antibodies to neutralize bioactive molecules in the gut microbiome. The primary goals are to 1) determine the impact of six proteins identified as overabundant in inflammatory gut disorders, and 2) evaluate the ability of immunoglobulin Y (IgY) antibodies to neutralize the physiological impacts...
This $2,166,750 project grant from the National Institutes of Health's National Institute of Environmental Health Sciences will fund research into the role of the gut microbiome in host adaptation to environmental xenobiotics. The University of California, Berkeley will explore how exposure to commonly used pesticides shapes the gut microbiome of the model organism C. elegans, and the long-term health consequences for the host. Researchers will characterize microbiome-assisted adaptation to...
The National Institute of General Medical Sciences (NIGMS) awarded a $1,338,750 Project Grant to Yale University to conduct research on how gut bacteria can influence host feeding behavior and microbiome assembly using the roundworm Caenorhabditis elegans as a model system. The project aims to develop tools and assays to study the molecular mechanisms by which gut microbes can manipulate host feeding decisions, with the goal of gaining insights that may apply to other host-microbe systems. Key...
This Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB), under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), will develop an innovative living biosensor system to more accurately profile the gut microbiome. The $548,949 award, effective August 1, 2024, will fund research at the University of California, San Diego to store and record extracellular DNA from gut microbes as they...
This federal Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to identify and engineer microbial enzymes that can selectively modulate the levels of peptidoglycan (PG) metabolites in the gut microbiome. The total funding amount is $224,807, with the award period running from Sep 1, 2024 to Mar 26, 2026. The key goals of this research project are to: 1) discover highly...
This federal Project Grant award from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) provides $393,718 to Massachusetts Institute of Technology (MIT) to study the biogeography and combinatorial effects of microbial and plant-derived redox-active small molecules on microbial growth and community composition. The key objectives of this research are to: 1) Use newly developed screens to identify redox-active metabolites...
This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $1,363,668.00 over 4 years to investigate how gut bacteria adapt to high-fat diets and the consequences for host metabolic health. The research will use evolved gut microbial communities from genetically distinct mouse lines to: 1) identify genomic signatures of bacterial...
This federal Project Grant award of $854,736 from the National Institute of General Medical Sciences (NIGMS) Biomedical Research and Research Training Program (CFDA 93.859) aims to develop robust statistical methods for analyzing longitudinal microbiome studies. The grant funds the development of statistical tools to address key challenges in longitudinal microbiome research, including: (1) addressing batch effects, (2) identifying taxa associated with biomedical exposures or outcomes over time,...

ENZYMATIC DETERMINANTS OF GUT MICROBIAL METABOLIC BIOTRANSFORMATIONS - PROJECT SUMMARY/ABSTRACT THE HUMAN GUT IS A COMPLEX ECOSYSTEM, WHERE TRILLIONS OF MICROBES INTERACT WITH DIETARY AND HOST-DERIVED MOLECULES, MEDIATING BIOTRANSFORMATIONS THAT SIGNIFICANTLY AFFECT BOTH THE MICROBIAL COMMUNITY AND THEIR HUMAN HOSTS. CENTRAL TO THIS METABOLIC INTERPLAY ARE ENE-REDUCTASES, A VERSATILE CLASS OF OXIDOREDUCTASES THAT FACILITATE THE REDUCTION OF CARBON-CARBON DOUBLE BONDS TO SINGLE BONDS. STOOL METABOLOMICS DATA IMPLICATES THE EXISTENCE OF NUMEROUS UNIDENTIFIED ENE-REDUCTASES, CONSTITUTING A GAP IN OUR UNDERSTANDING OF GUT MICROBIAL METABOLISM. WHILE THESE ENZYMES ARE PIVOTAL IN MODULATING METABOLITE BIOAVAILABILITY, IMPACTING BOTH MICROBIAL PHYSIOLOGY AND HUMAN HEALTH, MOST REMAIN UNIDENTIFIED. THIS RESEARCH PROPOSAL AIMS TO SYSTEMATICALLY CHARACTERIZE NOVEL GUT MICROBIAL ENE-REDUCTASES BASED ON THE HYPOTHESIS THAT THESE ENZYMES PLAY A CRITICAL ROLE IN SHAPING THE CHEMICAL MILIEU OF THE GUT. TO ACHIEVE THIS GOAL, WE WILL DEVELOP A PLATFORM THAT FUSES MICROBIOLOGY, BIOCHEMISTRY, AND BIOINFORMATICS IN A FOUR-STAGE STRATEGY TO SYSTEMATICALLY IDENTIFY AND CHARACTERIZE GUT MICROBIAL ENE- REDUCTASES RESPONSIBLE FOR THE REDUCTION OF A TARGET METABOLITE. FIRST, WE WILL IDENTIFY MICROBIAL STRAINS CAPABLE OF METABOLITE REDUCTION. SECOND, WE WILL IDENTIFY CANDIDATE REDUCTASE GENES THROUGH COMPARATIVE GENOMICS AND RNA-SEQ. THIRD, WE WILL EXPERIMENTALLY VALIDATE THE CANDIDATE ENZYMES FOR THEIR REDUCTASE ACTIVITY. FOURTH, STUDIES WILL BE PERFORMED TO UNDERSTAND THE MECHANISTIC BASIS OF THE NOVEL ENZYMES. THROUGH THIS RESEARCH, WE AIM TO DEEPEN OUR UNDERSTANDING OF THE CHEMICAL DIALOGUES OCCURRING BETWEEN GUT MICROBES AND THEIR HOST. SPECIFICALLY, THE STUDY WILL ILLUMINATE THE ROLES THAT ENE-REDUCTASES PLAY IN PERFORMING CONSEQUENTIAL BIOTRANSFORMATIONS AND SHAPING MICROBIOME COMMUNITY STRUCTURE. WHILE THIS PROPOSAL FOCUSES ON FUNDAMENTAL CHARACTERIZATION OF KEY GUT MICROBIAL ENZYMES, IT LAYS THE GROUNDWORK FOR TRANSLATIONAL ADVANCEMENT BY UNCOVERING METABOLIC MECHANISMS THAT WILL ULTIMATELY FACILITATE PRECISE, PERSONALIZED MICROBIOME MODULATION.

Posted 7/1/24, 12:00 AM